Outpatient WITHDRAWAL MANAGEMENT (DETOX)

BayMark Health Services offers outpatient withdrawal management, known more commonly as accelerated detoxification or detox, through The Coleman Institute for Addiction Medicine. An innovative center for addiction treatment, The Coleman Institute is a highly effective, medically-supervised outpatient detox treatment center for opioids, alcohol and benzodiazepines.
The process of traditional detoxification can often be uncomfortable, even painful, causing understandable anxiety for patients wanting to free themselves of their addiction. The Coleman Institute’s withdrawal management program utilizing an accelerated outpatient detox method, incorporates medication to comfortably and quickly clear opiates and/or alcohol from a patient’s system within three to eight days.

Patients choose The Coleman Institute for Addiction Medicine for many reasons, including:

  • Customized treatment plans utilizing medications, including sedation, to minimize withdrawal symptoms and improve patient comfort
  • Accelerated, flexible outpatient detoxification with no general anesthesia or hospital stay required.
  • As little as three days for prescription pain medication or alcohol
  • As little as five days for heroin, fentanyl or kratom
  • As little as eight days for benzodiazepines or long-lasting opioids like methadone or Suboxone
  • Ongoing naltrexone therapy supports long-term recovery by reducing cravings, blocking opioids and preventing relapse.
  • Naltrexone implant: a small, painless implant under the patient’s skin where it slowly releases naltrexone for two months
  • Vivitrol injection: a branded version of naltrexone that is administered through a monthly injection
  • After-care support with long-term, abstinence-based treatment planning, referrals and case management services.

Naltrexone is a non-narcotic medication that blocks the opioid receptors in a person’s brain, dramatically reducing cravings. Naltrexone is non-addictive and does not block the production and release of the body’s natural endorphins. If a relapse occurs while an individual is taking naltrexone, the medication prevents the feeling of euphoria or “high”. 

Naltrexone aids in combatting the withdrawal symptoms and cravings experienced during the first few weeks or months of recovery. Freed from intense cravings and unable to get high, patients have the strength and support to look beyond their physical symptoms and begin to focus on treating the psychological aspects of recovery.

For more information, find the Outpatient Withdrawal Management program near you:

Now Available: BayMark's 2023 Treatment Outcomes ReportGet the Whitepaper